Autem Therapeutics Alternatives & Competitors
12 companies similar to Autem Therapeutics — EM-Powering Cancer Care
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Epitopea
Exploiting a new class of tumour specific antigens for cancer therapy
Montreal, Canada
OneChain Immunotherapeutics
Development of CAR-T candidates for the treatment of acute lymphoblastic leukemia and othe...
Instil Bio
Clinical-stage immuno-oncology company focused on developing patient specific immunotherap...
Track all Autem Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
TORL BioTherapeutics LLC
Advancing novel antibody-based therapies to transform the lives of cancer patients.
Culver City, United State...
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Harbinger Health
Pioneering the detection of early cancer.
Cambridge, United States
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
San Diego, United States
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
United Kingdom
Breakpoint Therapeutics
Modulating DNA damage responses to cure cancer
Hamburg, Germany
About Autem Therapeutics
EM-Powering Cancer Care
Cancer treatment using Autem Therapy, Supply of AutEMsys™ devices, Research and development in biotechnology
Cancer Patients, Healthcare Providers, Remote Medical Facilities
Oncology Therapy, Bioelectric Treatment, Non-invasive Treatment, Non-toxic Therapy, HCC, Liver Cancer, Solid Tumor Cancers, FDA Breakthrough Designation, AutEMsys™ Therapy, Electromagnetic Frequencies, Clinical Feasibility Studies, FDA Investigational Device Exemption (IDE), Pivotal Clinical Trials, Cancer Treatment Innovation, Medical Device Development
B2B2C, B2B
Product Sales, Usage Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Autem Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Autem Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.